The bioflavonoid galangin suppresses the growth of ehrlich ascites carcinoma in Swiss Albino mice: a molecular insight. (Q39376196)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434356%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

The bioflavonoid galangin suppresses the growth of ehrlich ascites carcinoma in Swiss Albino mice: a molecular insight (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434356%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434356%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Jai V Jaiswal

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434356%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sunil W Hajare

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434356%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

21 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434356%20AND%20SRC:MED&resulttype=core&format=json

Applied Biochemistry and Biotechnology

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434356%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434356%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434356%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

1325-1339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434356%20AND%20SRC:MED&resulttype=core&format=json

Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Vegetables, fruit, and cancer. I. Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Vegetables, fruit, and cancer. II. Mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Flavonoids, a class of natural products of high pharmacological potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

The neuroprotective potential of flavonoids: a multiplicity of effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Mechanism of action of flavonoids as anti-inflammatory agents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Soy isoflavones and virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Presence of Fatty Acid Synthase Inhibitors in the Rhizome ofAlpinia officinarumHance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Separation of flavonoids and phenolic acids from propolis by capillary zone electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Phytochemical compounds involved in the anti-inflammatory effect of propolis extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Plant antimutagenic agents, 2. Flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Effect of the flavonoid galangin on urinary bladder rat contractility in-vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Differential effects of flavonoid compounds on tumor promoter-induced activation of the human CYP1A2 enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Antigenotoxicity of galangin against N-methyl-N-nitrosourea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Apoptotic DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Caspases: killer proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

ADMET in silico modelling: towards prediction paradise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Can the pharmaceutical industry reduce attrition rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-012-9646-3

10.1007/S12010-012-9646-3

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434356%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference